A detailed history of Seven Mile Advisory transactions in Johnson & Johnson stock. As of the latest transaction made, Seven Mile Advisory holds 4,841 shares of JNJ stock, worth $766,572. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,841
Previous 4,757 1.77%
Holding current value
$766,572
Previous $753 Million 5.97%
% of portfolio
0.52%
Previous 0.57%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$144.38 - $157.78 $12,127 - $13,253
84 Added 1.77%
4,841 $708 Million
Q1 2024

May 08, 2024

BUY
$155.22 - $162.74 $104,152 - $109,198
671 Added 16.42%
4,757 $753 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $100,609 - $109,786
691 Added 20.35%
4,086 $640 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $62,923 - $70,489
404 Added 13.51%
3,395 $529 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $461,660 - $496,835
2,991 New
2,991 $495 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $414B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.